US Stock MarketDetailed Quotes

HOLX Hologic

Watchlist
  • 78.600
  • +1.060+1.37%
Close Nov 15 16:00 ET
  • 77.862
  • -0.738-0.94%
Post 17:00 ET
18.26BMarket Cap23.67P/E (TTM)

About Hologic Company

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Company Profile

SymbolHOLX
Company NameHologic
Listing DateMar 2, 1990
Issue Price14.00
Founded1985
CEOMr. Stephen P. Macmillan
MarketNASDAQ
Employees6990
Fiscal Year Ends09-30
Address250 Campus Drive
CityMarlborough
ProvinceMassachusetts
CountryUnited States of America
Zip Code01752
Phone1-508-263-2900

Company Executives

  • Name
  • Position
  • Salary
  • Stephen P. Macmillan
  • Chairman of the Board, Chief Executive Officer and President
  • 15.56M
  • Karleen M. Oberton
  • Chief Financial Officer
  • 3.93M
  • Essex D. Mitchell
  • Chief Operating Officer
  • 2.17M
  • Benjamin J. Cohn
  • Vice President, Corporate Controller and Principal Accounting Officer
  • --
  • Peter Paul Dunne
  • Senior Vice President, Human Resources
  • --
  • Brandon Schnittker
  • Division President, GYN Surgical Solutions
  • --
  • Erik Anderson
  • Division President, Breast and Skeletal Health Solutions
  • --
  • Jennifer Schneiders
  • President, Diagnostics Solutions
  • --
  • Jan Verstreken
  • Group President, International
  • 3.52M
  • Charles J. Dockendorff
  • Independent Director
  • 344.96K
  • Dr. Ludwig N. Hantson, PhD
  • Independent Director
  • 319.96K
  • Sally Wellinghoff Crawford
  • Lead Independent Director
  • 374.96K
  • Amy A. Wendell
  • Independent Director
  • 319.96K
  • Scott T. Garrett
  • Independent Director
  • 339.96K
  • Stacey D. Stewart
  • Independent Director
  • 338.44K
  • Nanaz Mohtashami
  • Independent Director
  • 128.96K
  • Christiana Stamoulis, M.B.A.
  • Independent Director
  • 319.96K
  • John M. Griffin
  • General Counsel
  • 3.34M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data